Chemoinformaics analysis of Ethyl 3-hydroxyoctanoate
| Molecular Weight | 188.267 | nRot | 7 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 1 |
| Exact Molecular Weight | 188.141 | nRing | 0 |
| Solubility: LogS | -2.198 | nHRing | 0 |
| Solubility: LogP | 2.515 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 32.4419 |
| nHD | 1 | BPOL | 22.6681 |
| QED | 0.49 |
| Synth | 2.384 |
| Natural Product Likeliness | 0.979 |
| NR-PPAR-gamma | 0.191 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.036 |
| Pgp-sub | 0.314 |
| HIA | 0.003 |
| CACO-2 | -4.35 |
| MDCK | 0.0000644 |
| BBB | 0.977 |
| PPB | 0.643142 |
| VDSS | 0.745 |
| FU | 0.444948 |
| CYP1A2-inh | 0.709 |
| CYP1A2-sub | 0.623 |
| CYP2c19-inh | 0.386 |
| CYP2c19-sub | 0.702 |
| CYP2c9-inh | 0.176 |
| CYP2c9-sub | 0.477 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.104 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.252 |
| CL | 11.69 |
| T12 | 0.843 |
| hERG | 0.028 |
| Ames | 0.015 |
| ROA | 0.015 |
| SkinSen | 0.736 |
| Carcinogencity | 0.204 |
| EI | 0.981 |
| Respiratory | 0.071 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.82679 |